The report provides insights into GSK's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) ...
GSK PLC (GSK) reports robust sales and profit growth, while navigating external pressures in the vaccine market and preparing for future product approvals.
January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.
Q4 2024Management ViewCEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over ...
Evening Standard on MSN6d
GSK and Oxford researchers to create cancer vaccine to stop disease developingThis partnership represents a step forward in cancer research Professor Irene Tracey, University of Oxford Tony Wood, chief ...
Slaughter and May has elected David Johnson as its next managing partner, succeeding Deborah Finkler in the role. The change ...
GlaxoSmithKline is to team up with two UK ... is just one of a new generation of public-private partnerships in drug discovery being set up across the world. But the scale and depth of this ...
Mike Ralston, CEO of Blencowe Resources (BRES) and Manuel Pablo Zúñiga-Pflücker, President and CEO of PetroTal (PTAL) will be presenting and taking live Q&A at focusIR's Investor Webinar on Tuesday ...
Blake Lively introduced an alleged rough cut of It Ends With Us at Colleen Hoover’s Book Bonanza in 2024. Footage from the ...
GSK has made a $70 million down payment to expand the partnership, with an undisclosed minimum financial commitment over three years that can be extended to five if desired. Image Phil Taylor ...
A Feature on M&A, VC investment licensing and partnerships focusing on novel targets in autoimmune diseases.
Banco Santander (BME: SAN) shares spiked over 6% on Wednesday after the lender unveiled plans for €10 billion (£8.3 billion) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results